Search results
15 wrz 2020 · Survival has improved, but varies widely by GPA for patients with non–small-cell lung, breast, melanoma, GI, and renal cancer with brain metastases from 7-47 months, 3-36 months, 5-34 months, 3-17 months, and 4-35 months, respectively.
- PDF
PURPOSEConventional wisdom has rendered patients with brain...
- Journal of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology,...
- PDF
Proton therapy is a high-energy beam that precisely targets tumor cells in the brain to destroy their DNA. Damaging the tumor’s DNA makes it difficult or impossible for the cells to multiply, which stops them from growing and can eventually shrink them.
28 mar 2024 · Proton therapy is a rapidly growing advanced external beam radiotherapy modality used to treat malignant and benign tumors, with a potential clinical advantage on the basis of the elimination of medically unnecessary exit-dose compared with conventional x-ray (photon) radiotherapy.
Proton therapy (PT) has been administered for many years to a number of cancers, including brain tumours. Due to their remarkable physical properties, delivering their radiation to a very precise brain volume with no exit dose, protons are particularly appropriate for these tumours.
Proton therapy is an efficient alternative to photonic radiotherapy for the treatment of intra cranial or cervical benign tumors. •. For these tumors, proton therapy could reduce neurocognitive impairment and risk of radio-induced secondary cancers. •. Proton therapy achieves excellent local control with low toxicity rates. •.
29 wrz 2021 · Proton therapy (PT) is delivered to complex brain tumors to obtain an optimal curative treatment with limited toxicity. Value-based oncological medicine is increasingly important, particularly when long-term survival is to be expected.
This review details the indication of brain tumors for proton therapy and give a list of the open prospective trials for these challenging tumors.
